Metcela

Metcela is a Japan-based biotechnology company that researches, develops and commercializes fibroblast-based cell therapy for the treatment of cardiovascular diseases.

Business Model:

Revenue: $4M

Employees: 11-50

Detailed Metcela Information

Geographic Data

Metcela headquarters map

Address: Life Innovation Center 3-25-22

City: Kawasaki

State: kanagawa prefecture

Zip: 210-0821

Country: JP

Financial Info

Stage:

series c

Raised Last:

$14M

Raised Total:

$35M

Metrics

4,350,498Website Global Rank

2,337Website Monthly Traffic

Twitter Followers

Description

Metcela is a Japan-based biotechnology company that researches, develops and commercializes fibroblast-based cell therapy for the treatment of cardiovascular diseases.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
3/2020 Series B $0 Japan Lifeline
Joyo Bank
Joyo Industrial Research Institute
Sony Innovation Fund
Tsukuba Exceed Fund
Japan Lifeline
Joyo Bank
Joyo Industrial Research Institute
Sony Innovation Fund
Tsukuba Exceed Fund
1/2021 Series B $0 Alfresa Holdings
Dai-ichi Life
Eight Roads Ventures
F-Prime Capital
Japan Lifeline
KSP
MAKOTO Capital
Sony Innovation Fund
Tsukuba Exceed Fund
UTEC - The University of Tokyo Edge Capital Partners
Alfresa Holdings
Dai-ichi Life
Eight Roads Ventures
F-Prime Capital
Japan Lifeline
KSP
MAKOTO Capital
Sony Innovation Fund
Tsukuba Exceed Fund
UTEC - The University of Tokyo Edge Capital Partners
9/2018 Series A $4.6M Beyond Next Ventures
Eight Road Ventures Japan
F-Prime Capital Partners
Japan Lifeline Co.
Sony Innovation Fund
The Dai-ichi Life Insurance Company, Limited
5/2020 Series B $4M Japan Lifeline Co., Ltd.
Sony Innovation Fund
Joyo Bank
6/2022 Series C $0 CEJ Fund
Cyberdyne
Japan Lifeline
Reazon Holdings
Sony Innovation Fund
CEJ Fund
Cyberdyne
Japan Lifeline
Reazon Holdings
Sony Innovation Fund
8/2018 Series A $0 Beyond Next Ventures
Dai-ichi Life
Eight Roads Ventures
F-Prime Capital
Japan Lifeline
KSP
NEDO
Sony
Beyond Next Ventures
Dai-ichi Life
Eight Roads Ventures
F-Prime Capital
Japan Lifeline
KSP
NEDO
Sony
9/2018 Grant 1 - NEDO
NEDO
6/2022 Series C $14M CYBERDYNE Inc.
Japan Lifeline Co., Ltd
Sony Innovation Fund
Reazon Holdings, Inc.
1/2021 Series B 10 $12.7M University of Tokyo Edge Capital Partners
Alfresa Corporation,
Dai-ichi Life Insurance Company
MAKOTO CapitaL
KSP Inc
Japan Lifeline Co., Ltd
Sony Innovation Fund
Alfresa Holdings
Dai-ichi Life
Eight Roads Ventures
F-Prime Capital
Japan Lifeline
KSP
MAKOTO Capital
Sony Innovation Fund
Tsukuba Exceed Fund
UTEC - The University of Tokyo Edge Capital Partners
6/2022 Series C 5 $13.7M CEJ Fund
Cyberdyne
Japan Lifeline
Reazon Holdings
Sony Innovation Fund
CEJ Fund
Cyberdyne
Japan Lifeline
Reazon Holdings
Sony Innovation Fund
3/2020 Series B 5 $4M Japan Lifeline
Joyo Bank
Joyo Industrial Research Institute
Sony Innovation Fund
Tsukuba Exceed Fund
Japan Lifeline
Joyo Bank
Joyo Industrial Research Institute
Sony Innovation Fund
Tsukuba Exceed Fund
9/2018 Grant 1 - NEDO
NEDO
8/2018 Series A 8 $4.7M Beyond Next Ventures
Dai-ichi Life
Eight Roads Ventures
F-Prime Capital
Japan Lifeline
KSP
NEDO
Sony
Beyond Next Ventures
Dai-ichi Life
Eight Roads Ventures
F-Prime Capital
Japan Lifeline
KSP
NEDO
Sony
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research